The present invention relates to triazine compounds having sodium channel blocking properties, and to use of the compounds for preparation of medicaments for treatment of associated disorders. The compounds are of formula (I): in which z is a single bond or an optionally substituted linking group, R1 is a halo-alkyl group; and A is an optionally substituted aromatic heterocyclic or carbocyclic ring system; or a salt thereof.
本发明涉及具有
钠通道阻断性能的三嗪化合物,以及使用该化合物制备治疗相关疾病的药物。该化合物的公式为(I):其中z是单键或可选择性取代的连接基团,R1是卤代烷基;A是可选择性取代的芳香杂环或碳环系统;或其盐。